INTRODUCTION
Even if mechanical ventilation remains the cornerstone of treatment for respiratory failure, it is now clear that it can itself aggravate or cause lung damage inducing the so called ventilator-induced lung injury (VILI) through a variety of mechanisms.
The main mechanical determinant of VILI is regional lung overdistension due to high trans-pulmonary pressure (stress) that causes the lung to deform above its resting volume (strain) [1] .
In experimental models, VILI has been found to develop when a lung strain (estimated as the ratio between lung volume change and resting volume) greater than 2 is achieved, corresponding to a tidal volume approximately greater than 20 ml/kg in healthy animals [1, 2] . Thus, the smaller the resting lung volume, the greater the strain for a given lung volume change (inflation).
But low lung volume ventilation may also be deleterious due to regional amplification of forces and repetitive opening and closing of distal, collapsed lung units (atelectrauma) [3, 4] . This condition has been advocated to provide augmented pulmonary injury when tidal ventilation starts below and ends above the lower inflection point on the pressure/volume curve, as compared with ventilation starting above the lower inflection point.
The biotrauma concept relies on the hypothesis that lung tissue stretching might result in lung epithelium damage through the release of inflammatory mediators and leukocyte recruitment. Two mechanisms are believed to be responsible for this mechanical ventilator-induced inflammatory response. The first is direct trauma to the cell with disruption of cell walls, resulting in the release of cytokines into both the alveolar space and the systemic circulation [5] . Regarding the second, invitro studies have shown that most pulmonary cells can produce cytokines in response to cyclic stretch [6] .
Ranieri et al. [7] were the first to suggest that the mechanical ventilator-induced inflammatory response may contribute to development of multiple system organ dysfunction seen in mechanically ventilated patients with acute respiratory distress syndrome (ARDS) by initiating or propagating a malignant, systemic inflammatory response. Although it remains unclear how inflammatory mediators exert their detrimental effects on distal organs, experimental studies and clinical trials in ARDS have shown that the application of protective ventilator strategies is associated with decreased serum cytokine levels [8, 9] , decreased extrapulmonary organ dysfunction [7] , and decreased mortality [10] .
Many factors contribute to the development of VILI: the type, duration and intensity of physical forces generated by the ventilation (volume and pressure) as well as the cause, timing of lung injury and the general progression of the disease, and a large number of trials reported the clinical efficacy of a 'protective' ventilatory strategy based on the reduction of tidal volume to 6 ml/kg of ideal body weight and the limitation of end-inspiratory pressure to 30 cmH 2 O.
However, these recommendations are challenged by results of recent studies showing that patients with ARDS may be exposed to forces that can induce injurious ventilation despite values of plateau pressure (Pplat) of 30 cmH 2 O or less [11] [12] [13] ; and impairment of chest wall mechanics compromises the ability of Pplat to reflect overdistension [1, 14, 15] .
In the present study, we will discuss the pros and cons of the different approaches proposed to minimize VILI in patients with ARDS.
'PROTECTIVE' VENTILATORY STRATEGIES Different approaches have been proposed to minimize VILI in patients with ARDS.
Low tidal volume
Experimental and clinical data showed that a reduction of tidal volume reduced mortality in ARDS ventilated patients [10, 16, 17] but controversy exists regarding the extent to which tidal volume should be reduced to protect the lungs from VILI.
The ARDSnet study demonstrated that a 22% reduction in mortality could be obtained by using a tidal volume of 6 ml/kg predicted body weight (PBW) instead of 12 ml/kg PBW [10] . But it is still debated whether the tidal volume should be strictly set to 6 ml/kg PBW in all patients with ARDS, as the resulting strain will depend on the amount of ventilated tissue rather than on PBW [11] .
The development of tools for measurement of the amount of lung open to ventilation at bedside might allow for individual adjustment of tidal volume. These include promising noninvasive imaging methods, such as electrical impedance tomography and lung ultrasound, but also functional dynamic indexes, such as the stress index, which describes the shape of the airway pressuretime curve profile and may indicate tidal recruitment or tidal overdistension [18 && ]. Of note, patients with ARDS often 'fight the ventilator,' and this may aggravate VILI [19] . In a recent multicenter, placebo controlled, randomized trial involving 340 patients with ARDS and a PaO 2 : FiO 2 ratio of less than 150 mmHg, Papazian et al. [20] found that the adjusted 90-day mortality was lower among those who received a neuromuscular blocking agent for 48 h than among those who received placebo, without any increase in residual muscle weakness. The precise mechanism for the decreased mortality is unclear [19] but a previous study showed reduced serum cytokine levels among patients receiving a neuromuscular blocking agent [21] .
KEY POINTS
Mechanical ventilation, although necessary to preserve life, can itself aggravate or cause the so called VILI through a variety of mechanisms resulting in injury to the blood-gas barrier (endothelial, epithelial, and basement membrane) with consequent increase in microvascular permeability and lung rupture.
A large number of trials tried to identify strategies to improve the outcome of mechanically ventilated patients but only studies based on the physiological approaches for minimizing VILI really improved the outcome.
In the last years, the most important innovation is represented by the progressive change of approach, from basic mechanical respiratory support, to protective or ultraprotective noninjurious ventilation.
It is advisable for clinicians to integrate physiological principles with clinical data through a 'running assessment' of respiratory mechanics at the bedside so as to set up the most protective (tailor made) ventilatory strategy.
'High' positive end-expiratory pressure Early trials comparing lower with higher levels of positive end-expiratory pressure (PEEP) in patients with ARDS found no difference in mortality between the two groups. However, lower rates of hypoxemia were observed when higher PEEP and recruitment maneuvers were combined with protective ventilation in an 'open lung' strategy. Furthermore, the results of a large randomized controlled trial demonstrated that an 'increased recruitment strategy', wherein PEEP was used to reach a plateau pressure of 28-30 cm H 2 O, resulted in a greater number of ventilator-free days and days free of organ failure [22] [23] [24] . There is some evidence to suggest that higher levels of PEEP may benefit patients with a greater degree of lung injury. One recent meta-analysis demonstrated a statistically significant reduction in hospital mortality with the use of higher PEEP when compared with lower PEEP in the subset of patients with PaO 2 :FiO 2 less than 200 mmHg. No such benefit was seen in those with less severe hypoxemias [25] . This adds weight to a previous subgroup analysis of earlier trials, which concluded that higher levels of PEEP benefit the most-hypoxemic patients with ARDS [26] .
Recruitment maneuvers
Although such maneuvers were used in some trials that were included in the meta-analysis described above [25] and were implemented in a protective strategy that increased the number of lungs retrieved from heart-beating donors [27] , the role of recruitment maneuvers in clinical practice remains uncertain because of questions about its effect on outcomes and concerns regarding complications (e.g., hemodynamic compromise or pneumothorax) [28] .
Prone position
Prone positioning may mitigate VILI in three key ways: first, by providing a more homogeneous distribution of transpulmonary pressure throughout the lung, second, by 'resting' anterior lung units, which are subjected to the most overdistension, and third, by improving ventilation-perfusion matching, thereby allowing for a decrease in the inspired oxygen concentration [29, 30] .
Despite this, four randomized clinical trials [31] [32] [33] [34] have so far failed to demonstrate a reduction in mortality with its routine use in ARDS even if four meta-analyses concluded that although routine prone position ventilation offers no survival benefit in patients with ARDS, it does improve oxygenation [35] [36] [37] [38] . One more demonstrated the efficacy only in a selected category of very hypoxemic patients lowering absolute mortality. Starting from these assumptions, Guérin et al. [39 & ] designed a prospective, multicenter, randomized controlled trial to explore whether early application of prone positioning would improve survival among patients with ARDS who, at the time of enrollment, were receiving mechanical ventilation with PEEP of at least 5 cmH 2 O and in whom the PaO 2 /FiO 2 ratio was less than 150 mmHg. The trial confirmed the improvement in patient survival with prone positioning reducing the rate of 28-day mortality from 32.8% (supine group) to 16.0% (prone group) [39 & ].
High-frequency oscillatory ventilation
Theoretically, this technique should be ideal for minimizing VILI [40] . In a meta-analysis of eight randomized, controlled trials involving a total of 419 adults with ARDS [41] , high-frequency oscillatory ventilation-treated patients had significantly lower mortality than did patients treated with conventional ventilation (risk ratio, 0.77; P ¼ 0.03), which suggested that high-frequency oscillatory ventilation might improve survival and is unlikely to cause harm. Unfortunately, these benefits usually come at the expense of markedly increased mean airway pressures [42] and the potential deterioration in right heart function and organ perfusion.
Transpulmonary pressure
ARDS patients are particularly prone to VILI due to inhomogeneous parenchyma damage that presents areas not aerated (with atelectasis, infiltrates, or effusions), areas with low ventilation in which the opening-closing phenomenon is prevalent, areas normally aerated without signs of stress, and lastly areas overinflated. In this context, the best ventilatory strategy should be ideally adapted to the size of the aerated lung. It is hence necessary to move from the selection of mode and setting of the ventilator based on a fixed set of numbers, to take into account the transpulmonary pressure [43 && ], that is, the difference between alveolar pressure and pleural pressure, which is considered by some as the main determinant of VILI [44] .
The importance of transpulmonary pressure in adjusting mechanical ventilation setting in ARDS patients has even been studied by Talmor et al. [45] in 2008. In a randomized, single-center trial, they found an improvement in oxygenation and a reduction in 28-day mortality by setting the PEEP at such a level that transpulmonary pressure during end-expiratory occlusion ranged between 0 and 10 cmH 2 O and during end-inspiratory occlusion remained lower than 25 cmH 2 O. Different methods have been proposed in literature to estimate transpulmonary pressure: [45] Recently, Chiumello et al. [46] reported that the two methods are similar and concluded that the transpulmonary pressure can be satisfactorily estimated by the first one, which does not require any disconnection from the ventilator, thereby avoiding possible risks of lung derecruitment and hypoxemia due to the loss of PEEP.
'SUPER PROTECTIVE' VENTILATORY STRATEGY
Extracorporeal life support (ECLS) techniques, such as extracorporeal membrane oxygenation (ECMO) or extracorporeal CO 2 removal (ECCO 2 R), are known to provide adequate gas exchange in patients with ARDS [47] . Vast improvements in ECLS technology over the last decade have made these devices less invasive, more biocompatible, and easier and safer to use. Moreover, ECLS can facilitate the use of 'ultra' protective mechanical ventilation (e.g., employing tidal volume <6 ml/kg PBW and lower airway pressures) in patients supported with ECLS, minimizing the risk of VILI. More radically, patients supported with ECLS may not require intubation or invasive mechanical ventilation at all: no ventilation, no VILI.
EXTRACOPOREAL MEMBRANE OXYGENATION
The safety, clinical efficacy and cost-effectiveness of extracoporeal membrane oxygenation (ECMO) compared with conventional ventilation support has been recently been studied in the Conventional Ventilation or ECMO for Severe Adult Respiratory Failure (CESAR) study [48] . A significant improvement in survival without severe disability at 6 months was found in patients transferred to a specialist center for consideration for ECMO compared with continued conventional ventilation. This result has been attributed to the fact that ECMO was able to sustain life in acute lung failure long enough for diagnosis, treatment and recovery. Moreover, ECMO was able to rest the lungs from high pressure and FiO 2 ventilation, thereby keeping to minimum the iatrogenic contribution to lung injury.
EXTRACORPOREAL CO 2 REMOVAL
In a recent study, Terragni et al. [12] evaluated whether tidal volume less than 6 ml/kg PBW may enhance lung protection. In 32 patients with ARDS ventilated with a tidal volume of 6 ml/kg PBW, those with plateau pressures between 28 and 30 cm H 2 O had their tidal volume reduced to achieve plateau pressures between 25 and 28 cm H 2 O. Respiratory acidosis (pH 7.25) was managed with ECCO 2 R for at least 72 h. Patients who already had plateau pressures between 25 and 28 cm H 2 O continued to receive mechanical ventilation with tidal volume of 6 ml/kg PBW. In the ECCO 2 R group (10 patients), PaCO 2 (mean 50 mmHg) and pH (mean 7.32) were normalized, and tidal volume was reduced from 6 to 4 ml/kg PBW and plateau pressure decreased from 29 to 25 cmH 2 O (P < 0.001). Moreover, there was a significant reduction in the morphological markers of lung injury and pulmonary cytokines (P < 0.01) in the ECCO 2 R group after 72 h of mechanical ventilation with tidal volume lower than 6 ml/kg PBW. Of note, no patient-related complications occurred in patients receiving ECCO 2 R.
Although promising, the putative benefits of 'ultra' protective mechanical ventilation with ECCO 2 R, or more complete gas exchange support with ECMO, in patients with ARDS requires confirmation in large, randomized controlled trials [49] .
CONCLUSION
From a theoretical prospective, all patients receiving ventilator support should benefit from noninjurious strategies. It is advisable for clinicians to integrate physiological principles with clinical data through a 'running assessment' of respiratory mechanics at the bedside so useful to contain VILI by the early identification of specific lung alterations and the resulting most-protective (tailor made) ventilatory strategy.
Future study, already planned, is expected to improve further the clinical outcomes compared with standard-of-care lung-protective ventilation in patients with ARDS. The EOLIA trial (ECMO to rescue lung injury in severe ARDS; ClinicalTrials.gov NCT01470703) is going to evaluate the impact of ECMO, instituted early after the diagnosis of ARDS not evolving favorably after 3-6 h under optimal ventilatory management and maximum medical treatment, on the morbidity and mortality associated with this disease, whereas the SUPERNOVA trial (A Strategy of UltraProtective lung ventilation with Extracorporeal CO 2 Removal for NewOnset moderate to seVere ARDS; ESICM trial groupregistration ongoing) will evaluate whether a strategy of enhanced lung-protective (lower tidal volume and lower pressure) ventilation, along with control of the ensuing hypercapnia using the latest
